Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Researchers from the University of Oxford are using artificial intelligence to improve diagnostic accuracy for heart disease. The team hope to roll out the system across the NHS later this year, helping to improve patient outcomes and saving millions is misdiagnoses. The research, led by Prof Paul Leeson and RDM DPhil student Ross Upton (Cardiovascular Clinical Research Facility), took place in the Oxford University Hospitals Foundation Trust and is the basis of spin-out company Ultromics.

Thousands of people every year have an echocardiogram – a type of heart scan – after visiting hospital suffering with chest pain. Clinicians currently assess these scans by eye, taking into account many features that could indicate whether someone has heart disease and if they are likely to go on to have a heart attack. But even the most well trained cardiologist can misdiagnose patients. Currently, 1 in 5 scans are misdiagnosed each year – the equivalent to 12,000 patients. This means that people are either not being treated to prevent a heart attack, or they are undergoing unnecessary operations to stave off a heart attack they won’t have.

The new system uses machine learning – a form of artificial intelligence – to tap into the rich information provided in an echocardiogram. Using the new system, AI can detect 80,000 subtle changes inviable to the naked eye, improving the accuracy of diagnosis to 90%. The machine learning system was trained using scans from previous patients, alongside data about whether they went on to have a heart attack. The team hope that the improved diagnostic accuracy will not only improve patient care and outcomes, but save the NHS £300million a year in avoidable operations and treatment.  

Ross Upton discusses the new system with BBC World News.

So far the system has been trialled in six cardiology units in the UK. Further implementation of the technology is now being led by Ultromics – a spin-out company co-founded by Ross Upton and Paul Leeson (Cardiovascular Clinical Research Facility). The software will be made available for free throughout the NHS later this year.

Similar stories

New blood test from DPAG cardiac researchers could save lives of heart attack victims

Researchers from the Herring group have developed a blood test that measures stress hormone levels after heart attacks. The test – costing just £10 – could ensure patients receive timely life-saving treatment.

Professor Barbara Casadei awarded 2022 Nylin Medal

The Swedish Society of Medicine has awarded the 2022 Nylin Medal to Professor Barbara Casadei, part of the Oxford BHF CRE leadership team.

Joaquim Vieira recognised in national image competition

DPAG BHF Intermediate Research Fellow Dr Joaquim Vieira has been shortlisted for the British Heart Foundation’s annual ‘Reflections of Research’ image competition.

Study develops radiotranscriptomic AI analysis to enable virtual heart biopsies

RDM researchers tested the method in COVID-19 patients, to find that the results predicted in-hospital mortality.

BHF Senior Fellowship renewal for Duncan Sparrow could pave the way to revealing unknown causes of heart defects in babies

Congratulations are in order for Associate Professor Duncan Sparrow, who has been awarded a renewal of his British Heart Foundation Senior Basic Science Research Fellowship. The award will fund crucial investigations into little understood environmental risk factors of congenital heart disease, and could one day lead to new therapeutic strategies.

Joaquim Vieira brings heart regeneration research to the public at Pint of Science

Pint of Science is the world’s largest public science festival bringing researchers to local pubs, cafes and spaces to share their scientific discoveries with the public.